Drug Type Small molecule drug |
Synonyms ODM 207 |
Target |
Mechanism BET inhibitors(Bromodomain and extra terminal domain protein inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H21N3O3 |
InChIKeyYVGWSVHZXWFLIT-UHFFFAOYSA-N |
CAS Registry1801503-93-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 2 | FI | 22 Dec 2016 | |
Solid tumor | Phase 2 | GB | 24 Jun 2016 | |
Breast Cancer | Phase 1 | IN | 25 Oct 2016 | |
Prostatic Cancer | Phase 1 | FI | 25 Oct 2016 | |
Prostatic Cancer | Phase 1 | IN | 25 Oct 2016 |
Phase 1 | 35 | zypziorlqo(nwmmeznkpx) = hrombocytopenia, asthenia, nausea, anorexia, diarrhoea, fatigue, and vomiting zlsbqxcoyz (jefhrrnhfm ) View more | Positive | 01 Dec 2020 |